Table 2. Overview of beneficiary effects of milk fat globule membrane (MFGM) proteins and polar lipids (20, 27-29).
Component | Potential health effect |
---|---|
Fatty acid-binding protein | Cell growth inhibition Anticancer factor |
Butyrophillin | Suppression of multiple sclerosis influences pathogenesis of autistic behaviour |
Xanthine dehydrogenase/oxidase | Bactericidal agent Anti-inflammatory action |
Breast cancer type 1 susceptibility protein | Inhibition of breast cancer |
Breast cancer type 1 susceptibility protein | |
Sphingolipids and metabolites | Shift in tumour type from malignant to benign Anticholesterolemic protection of the liver from fat- and cholesterol-induced steatosis Suppression of gastrointestinal pathogens (Campylobacter jejuni, Listeria monocytogenes, Clostridium perfrigens, Escherichia coli, Salmonella enteritidis) Neonatal gut maturation Myelination of the developing central nervous system Endogenous modulators of vascular function |
Phosphatidylserine | Restoring normal memory of a variety of tasks Positive effects on Alzheimer patients (daily intake 200 mg) Improving exercise capacity of exercising humans |
Phosphatidylcholine | Supporting liver recovery from toxic chemical attack or viral damage Protection of the human GI mucosa against toxic attack Reduction of necrotising enterocolitis |
Mucins and glycoproteins | Inhibition of Helicobacter pylori Protective effect against rotavirus infections |
MFGM hydrolysates | Antimicrobial activity against pathogens |